glp-1 analog drugs of GLP-1RAs approved for the treatment of type 2 diabetes. FDA US Food The Impact of GLP-1 Receptor

How should I use Victoza

The end result

Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review

However, it can be continued post-cycle to support energy, metabolism, and performance as part of your PCT support stack

The search terms used were obesity, OSA, ASP, EDS, CPAP, glucagon-like peptide-1 (GLP-1), GLP-1 receptor (GLP-1R) agonists, liraglutide (LIRA), exenatide (EXE), semaglutide (SEMA), dulaglutide (DULA), sodium-glucose co-transporters 2 (SGLT2) inhibitors, empagliflozin (EMPA), dapagliflozin (DAPA), ertugliflozin (ERTU), canagliflozin (CANA), and luseogliflozin (LUSEO)

This occurs by metabolising various types of energy-providing substrates that are taken up from the blood circulation, and by changing the efficiency of utilization of different substrates as an adaptive response to altered physiological or metabolic environment 26